Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Aggregation of tau protein in the brain is associated with a class of neurodegenerative diseases known as tauopathies. FK506 binding protein 51 kDa (FKBP51, encoded by FKBP5) forms a mature chaperone complex with Hsp90 that prevents tau degradation. In this study, we have shown that tau levels are reduced throughout the brains of Fkbp5-/- mice. Recombinant FKBP51 and Hsp90 synergized to block tau clearance through the proteasome, resulting in tau oligomerization. Overexpression of FKBP51 in a tau transgenic mouse model revealed that FKBP51 preserved the species of tau that have been linked to Alzheimer's disease (AD) pathogenesis, blocked amyloid formation, and decreased tangle load in the brain. Alterations in tau turnover and aggregate structure corresponded with enhanced neurotoxicity in mice. In human brains, FKBP51 levels increased relative to age and AD, corresponding with demethylation of the regulatory regions in the FKBP5 gene. We also found that higher FKBP51 levels were associated with AD progression. Our data support a model in which age-associated increases in FKBP51 levels and its interaction with Hsp90 promote neurotoxic tau accumulation. Strategies aimed at attenuating FKBP51 levels or its interaction with Hsp90 have the potential to be therapeutically relevant for AD and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hsp90:FKBP51 functions in tau proteostasis, increasing its stability and altering phosphorylation states”
From The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state (2021) · cites this paper as Blair et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“since FKBP5 site-specific demethylation occurs with age (49).”
From Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation (2016) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Introduction Neurofibrillary tangles, hallmarks of a class of neurodegenerative diseases termed tauopathies, are comprised of microtubule-associated tau protein aggregates that persist in the brain even after neuron death (1).”
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487 · cited 2×
“3- to 4-times more abundant in cells than 26S proteasomes (35).”
Whitmore, L., & Wallace, B. A. (2008) · Biopolymers · doi:10.1002/bip.20853 · Cited by 2,243
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · cited 1×
“This same model displays cognitive recovery when tau is suppressed, despite continued tangle formation (5, 46).”
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
The Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“However, levels of neuronal death in AD far exceed what is expected based on the observed numbers of tau tangles (2), suggesting that a different mechanism is primarily responsible for neurodegeneration.”
Cited by
Items 201–300 of 324
Aha-type co-chaperones: the alpha or the omega of the Hsp90 ATPase cycle?
LaPointe, P., Mercier, R., & Wolmarans, A. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0341 · Cited by 11
Wang, L., Wojcieszak, J., Kumar, R., Zhao, Z., Sun, X., Xie, S., Winblad, B. G., & Pavlov, P. F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03627-x · Cited by 13
Self-citationLafta, M. S., Sokolov, A. V., Landtblom, A., Ericson, H., Schiöth, H. B., & Hamdeh, S. A. (2023) · European Journal of Pain · doi:10.1002/ejp.2231 · Cited by 11
Interplay of p23 with FKBP51 and their chaperone complex in regulating tau aggregation
Chakraborty, P., & Zweckstetter, M. (2025) · Nature Communications · doi:10.1038/s41467-025-56028-0 · Cited by 12
Zegarra-Valdivia, J. A., Arana‐Nombera, H. A., Perez‐Fernandez, L. A., Casimiro‐Arana, M. D. R., Gallegos‐Manayay, V. N., Oliva‐Piscoya, M. D. R., Alamo‐Medina, R. E., Abanto‐Saldaña, E. S., Ordinola, M. C. C., Paredes-Manrique, C., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040233 · Cited by 12
Mitra, G., Gupta, S., Poddar, A., & Bhattacharyya, B. (2015) · Biophysical Chemistry · doi:10.1016/j.bpc.2015.06.003 · Cited by 15
Kang, D., Baek, Y., & Lee, J. (2022) · Cells · doi:10.3390/cells11244062 · Cited by 10
“In mouse model, FKBP51 and Hsp90 blocks the clearance of tau and induces tau oligomerization, increasing tau toxicity [123].”
BackgroundHosseini, H. C., Rangchian, A., Prins, M. L., Giza, C. C., Ruberti, J. W., & Kavehpour, H. P. (2020) · Journal of Biomechanical Engineering · doi:10.1115/1.4046330 · Cited by 11
Emerging roles of PHLPP phosphatases in the nervous system
Mallick, A., Sharma, M., & Dey, C. S. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103789 · Cited by 9
Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction
Wang, L., Kumar, R., Winblad, B. G., & Pavlov, P. F. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116356 · Cited by 8
Self-citationFaborode, O. S., Dallé, E., & Mabandla, M. V. (2022) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2022.107611 · Cited by 9
Hu, J., Luo, Y., & Wang, X. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100128 · Cited by 10
“Finally, transcriptome data from the 8 CE brain tissues datasets (GSE106241 [ 15 ], GSE28146 [ 16 ], GSE118553 [ 17 ], GSE48350 [ 18 ], GSE122063 [ 19 ], GSE5281 [ 20 ], GSE132903 [ 21 ], and GSE84422 [ 22 ]) and 3 CE blood samples datasets (GSE63060 [ 23 ], GSE63061 [ 23 ], and GSE85426) were…”
Gradin, R., Lindstedt, M., & Johansson, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212669 · Cited by 8
Ayoub, C. A., Wagner, C. S., & Kuret, J. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010681 · Cited by 9
Sengupta, U., & Kayed, R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_9 · Cited by 10
Self-citationSUMO conjugation as regulator of the glucocorticoid receptor-FKBP51 cellular response to stress
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Ugo, M. B., & ARZT, E. S. (2019) · Steroids · doi:10.1016/j.steroids.2019.108520 · Cited by 8
Ge, X., Yao, T., Zhang, C., Wang, Q., Wang, X., & Xu, L. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220805120303 · Cited by 9
“FKBP5 knockout AD models exhibit few phenotypic changes or behavioral alterations [71, 72] and, tau levels were reduced throughout the brains of Fkbp5 -/- mice [73, 74].”
Adams, L., Song, M. K., Tanaka, Y., & Kim, Y. (2022) · medRxiv · doi:10.1101/2022.01.18.22269350 · Cited by 7
Epigenetics as a link between environmental factors and dementia risk
Koulouri, A., & Zannas, A. S. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241284227 · Cited by 8
“83,84 Life adversity has been further associated with epigenetic regulation of BDNF .”
Zhu, B., Cai, B., Xue, K., Zhou, S., Yin, G., & Fang, J. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70552 · Cited by 8
Khalaf, N. B. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1711422 · Cited by 9
Regulation of tau by peptidyl-prolyl isomerases
Zhuang, S., Chakraborty, P., & Zweckstetter, M. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102739 · Cited by 8
HPA flexibility and FKBP5 : promising physiological targets for conservation
Zimmer, C., Jimeno, B., & Martin, L. B. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0512 · Cited by 12
“Interestingly, Blair et al. [88] showed that FKBP5 expression and protein levels increased with age, which promoted the pathogenesis of Alzheimer ’ s disease.”
BackgroundPiergiorge, R. M., Francisco, R. D. S., de Vasconcelos, A. T. R., & Santos-Rebouças, C. B. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107494 · Cited by 6
Scheidemantel, L. P., Lopes, K. D. P., Gaiteri, C., Menon, V., Jager, P. L. D., Schneider, J. A., Buchman, A. S., Wang, Y., Tasaki, S., Raittz, R. T., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117235 · Cited by 7
“21,67,68 Conversely, the neurotrophin VGF (a nerve-growth-factor-inducible protein) and its derived peptides play a protective role in AD.”
Chen, Y., Li, C., Yao, Y., & Yazhen, S. (2024) · Current Alzheimer Research · doi:10.2174/0115672050338777241028071955 · Cited by 7
Jung, C., Yamashita, H., Kato, R., Zhou, C., Matsushita, H., Takeuchi, T., Abdelhamid, M., Chen, Y., & Michikawa, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032741 · Cited by 7
“On the contrary, ATP-binding cassette A1 (ABCA1) and apolipoprotein E (ApoE) are involved in Aβ clearance, and insulin-degrading enzyme (IDE) and neprilysin (NEP) are involved in Aβ degradation [26,27].”
BackgroundWilliams, K. E., Zou, Y., Qiu, B., Kono, T., Guo, C., Garcia, D. K., Chen, H., Graves, T. J., Lai, Z., Evans‐Molina, C., et al. (2023) · Cells · doi:10.3390/cells13010089 · Cited by 5
“Additionally, the level of FKBP51 protein also increases with age, an event associated with neurotoxic Tau accumulation and AD progression [98].”
BackgroundA novel estimator of between-study variance in random-effects models
Wang, N., Zhang, J., Xu, L., Qi, J., Liu, B., Tang, Y., Jiang, Y., Cheng, L., Jiang, Q., Yin, X., et al. (2020) · BMC Genomics · doi:10.1186/s12864-020-6500-9 · Cited by 5
Hsp90: Bringing it all together
Karras, G. I., Colombo, G., & Kravats, A. N. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.01.002 · Cited by 4
Chou, K.-N., Lu, X.-J., Lai, H.-F., Chiu, Y., & Shih, C. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110773 · Cited by 5
Molecular integrators of stress and aging: the example of FKBP5
Zannas, A. S. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02572-2 · Cited by 6
“Notably, FKBP5 expression was previously shown to be higher with advancing age and in Alzheimer’s disease across multiple human brain regions, and this upregulation was associated with concordant epigenetic modifications (DNA hypomethylation) at a gene regulatory site [1].”
BackgroundMolecular-level interplay between intrinsically disordered clients and Hsp90
Ramirez, L. M., & Zweckstetter, M. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102304 · Cited by 4
FKBP51 functions in the regulation of circadian rhythm and Alzheimer's disease
Johnson, J. L. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.02.002 · Cited by 4
Glucocorticoid-Dependent Epigenetic Regulation of Fkbp5
Lee, R. S. (2016) · Epigenetics and human health · doi:10.1007/978-3-319-24493-8_4 · Cited by 4
Siangphoe, U., Archer, K. J., & Mukhopadhyay, N. D. (2019) · BMC Bioinformatics · doi:10.1186/s12859-018-2491-9 · Cited by 4
Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases
Daneri-Becerra, C., Ciucci, S. M., Mazaira, G. I., & Galigniana, M. D. (2021) · Current Drug Targets · doi:10.2174/1389450121999201230204320 · Cited by 5
Whalen, K., & Freeman, B. (2026) · Cell stress & chaperones (Print) · doi:10.1016/j.cstres.2026.100190 · Cited by 3
Linville, R. M., James, B. T., Galani, K., Ho, L., Shin, J. H., Oliver, E., Fass, S. B., Cameron, J. C., Fitzwalter, B. E., Bock, R., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.006 · Cited by 5
Stress and the risk of Alzheimer dementia: Can deconstructed engrams be rebuilt?
Jeanneteau, F. D. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13235 · Cited by 4
“…in the brains of AD subjects compared to age-matched controls, suggesting that inhibitors of FKBP51 are desirable to restore GR functions in aging; 134 (v) the GR-regulated gene Kfl9 that acts as transcription factor reduces glucocorticoid efficacy under duress in mice, and genome editing-based…”
Zhang, J., Zhu, J., Zou, X., Liu, Y., Zhao, B., Chen, L., Li, B., & Chen, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32782 · Cited by 4
“Inhibition of Hsp90 has been shown to impede tau protein clearance, leading to the accumulation of neurotoxic tau and an increased risk of neurodegenerative diseases [55].”
Delving Into the Interaction Between Exercise and Diabetes on Methylation of the FKBP5 Gene
Yang, T., Tsai, J., Hsu, H., Chen, Y., Liaw, Y.-C., Hsu, S. Y., Yang, H. J., & Liaw, Y. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/1162708 · Cited by 3
“FKBP5 modulates GR sensitivity, linking it to stress-related disorders, including PTSD and metabolic diseases [51 – 55].”
Ferrari, L., & Rüdiger, S. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_21 · Cited by 3
Faborode, O. S., Dallé, E., & Mabandla, M. V. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113679 · Cited by 5
Structural Basis for Chaperone‐Independent Ubiquitination of Tau Protein by Its E3 Ligase CHIP
Munari, F., Mollica, L., Valente, C., Parolini, F., Kachoie, E. A., Arrigoni, G., D’Onofrio, M., Capaldi, S., & Assfalg, M. (2022) · Angewandte Chemie · doi:10.1002/ange.202112374 · Cited by 3
Functions of the Hsp90-Binding FKBP Immunophilins
Ortiz, N. R., Guy, N. C., Garcia, Y. A., Sivils, J. C., Galigniana, M. D., & Cox, M. B. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-14740-1_2 · Cited by 3
Experimental laboratory models as tools for understanding modifiable dementia risk
Sinclair, D., Canty, A. J., Ziebell, J. M., Woodhouse, A., Collins, J. M., Perry, S. E., Roccati, E., Kuruvilla, M. V., Leung, J. Y. K., Atkinson, R. A. K., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13834 · Cited by 2
SIRT6-dependent functional switch via K494 modifications of RE-1 silencing transcription factor
Zaretsky, A., García-Venzor, A., Eremenko, E., Stein, D., Smirnov, D., Rabuah, Y., Dryer, R. A., Kriukov, D. V., Kaluski-Kopatch, S., Einav, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07160-0 · Cited by 4
Criado‐Marrero, M., Blazier, D. M., Gould, L. A., Gebru, N. T., Ospina, S. R., Armendariz, D. S., Darling, A. L., Beaulieu‐Abdelahad, D., & Blair, L. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-11025-x · Cited by 3
Self-citationNeurodegenerative Diseases as Protein Folding Disorders
Baker, J. D., Webster, J. M., Shelton, L. B., Koren, J., Uversky, V. N., Blair, L. J., & Dickey, C. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00009-2 · Cited by 3
Self-citationFibril formation rewires interactome of the Alzheimer protein Tau by π-stackingPreprint
Ferrari, L., Stucchi, R., Konstantoulea, A., van de Kamp, G., Kos, R., Geerts, W. J. C., Förster, F. G., Altelaar, M. A. F., Hoogenraad, C. C., & Rüdiger, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/522284 · Cited by 3
Zannas, A. S., Jia, M., Hafner, K., Baumert, J. J., Wiechmann, T., Pape, J. C., Arloth, J., Ködel, M., Martinelli, S., Roitman, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/484709 · Cited by 5
“Interestingly, FKBP5 upregulation has been observed not only upon stress exposure and glucocorticoid stimulation, but also in the aging brain (20, 21) and in some disease phenotypes (15, 17, 20, 22).”
BackgroundSelf-citationTau protein aggregation: A therapeutic target for neurodegenerative diseases
Duggal, A., Mahindru, D., Baghel, K., Mehrotra, S., & Prajapati, V. K. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.11.012 · Cited by 5
Hormonal contraceptives modulate resilience to psychiatric and neurodegenerative disease
Schuh, K. M., Conrad, L. M., & Tronson, N. C. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105823 · Cited by 3
From stress to Alzheimer’s: A circuit-based framework for prefrontal cognitive dysfunction
Yi, J. H. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138424 · Cited by 3
Protein clearance mechanisms and their demise in age-related neurodegenerative diseases
Sáez, I., & Vílchez, D. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.1.1 · Cited by 2
“Notably, in humans, FKBP51 levels increase relative to age and higher FKBP51 levels are associated with AD progression [109].”
BackgroundEnvironmental factors and epigenetics of neuropsychiatric disorders
Hoffmann, A. H., & Spengler, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800226-1.00002-2 · Cited by 4
Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt-Jakob diseasePreprint
Dabin, L. C., Guntoro, F., Campbell, T., Bélicard, T., Smith, A. R., Smith, R. G., Raybould, R., Schott, J. M., Lunnon, K., Sarkies, P., et al. (2020) · medRxiv · doi:10.1101/2020.08.25.20181495 · Cited by 2
p23-FKBP51 chaperone complex regulates tau aggregationPreprint
Chakraborty, P., & Zweckstetter, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.27.573415 · Cited by 2
“Concurrently, FKBP51 is reported to synergize with Hsp90 to promote toxic tau oligomerization by forming an Hsp90-FKBP51-tau pro-toxic complex 32,33 .”
BackgroundBhat, V. N., & Raj, B. (2024) · Geriatric Pharmacology · doi:10.1080/2994399x.2025.2467461 · Cited by 2
FKBP51: A new target for Parkinson’s disease
García-Gómara, M., Cuadrado‐Tejedor, M., & García‐Osta, A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00651 · Cited by 1
“Notably, overexpression of Fkbp51 in a tauopathy mouse model preserved pathogenic tau species, further implicating this co-chaperone in the molecular mechanisms driving AD (Blair et al., 2013).”
InfluentialTian, X., Zhu, B., Zhou, X., Fang, W., Ye, L., Liu, M., Wu, N., Wen, N., & Li, H. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70849 · Cited by 2
Embracing change: Chemical modifications of nucleic acid bases as epigenetic marks
Nain, N., Khan, S., Phogat, P., Bansal, A., & Kukreti, S. (2025) · Next research. · doi:10.1016/j.nexres.2025.101292 · Cited by 1
Role of FK506 binding protein 51 in central nervous system diseases
Peng, H., Wei, Y., Qiu, Y., Bi, R., Zeng, L., Hu, B., & Li, Y. Q. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1725945 · Cited by 3
FKBP5 regulates interferon signaling leading to myeloid cell activation in multiple sclerosis
Cruz, C. G., Gibson, J., Kita, M., Sankpal, N. V., Piras, I. S., & Cantoni, C. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03703-8 · Cited by 2
“FKBP5 is classically associated with stress-related disorders [15–17], and its dysregulation has also been reported in MS [31, 32].”
A novel TGFβ1–Hs3st2–tau axis regulates tau pathology and synaptic integrity
Castillo‐Negrete, R., Merrick, H., Selvaraj, S., Huynh, M. B., Laffray, X., Thuraisamy, A., Diener, M., Jedlička, P., Ouidja, M. O., & Papy-García, D. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1726022 · Cited by 2
Guo, K., Li, X., Liang, Q., Chen, C., Lin, J., Zhan, T., Sun, C., Kang, N., Qiu, F. X., & Zhang, Q. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864261443823 · Cited by 1
“HSP90 promotes the misfolding and accumulation of tau, and may even strengthen their toxicity (Blair et al., 2013).”
Tang, Z., Xie, H., Xu, Y., Zhou, Z., Lu, F., Wu, Q., Liang, W., Zhong, M., & Li, S. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s602287 · Cited by 1
“6,29,30 Research by Oroz et al demonstrated that the Hsp90/FKBP51 complex acts as a pro-toxic scaffold, stabilizing tau in conformations prone to aggregation.”
Malcom, C. A., Guzeloglu‐Kayisli, O., Ün, B., New, E. P., Cetinkaya-Un, B., Guo, X., Mikhail, E., Imudia, A. N., Lockwood, C. J., & Kayisli, U. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf255
DNA Methylation in Cellular Mechanisms of Neurodegeneration
Neidhart, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420194-1.00018-x · Cited by 1
Santarriaga, S., Fikejs, A. S., Scaglione, J. B., & Scaglione, K. M. (2019) · mSphere · doi:10.1128/msphere.00314-19 · Cited by 1
Self-citationKumar, R., Winblad, B. G., & Pavlov, P. F. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_14 · Cited by 1
Matosin, N., Arloth, J., Czamara, D., Edmond, K. Z., Maitra, M., Fröhlich, A. S., Martinelli, S., Kaul, D., Bartlett, R., Curry, A. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.27.428487 · Cited by 1
“Specifically, FKBP5 DNAm associates with age in brain (Blair et al., 2013) and peripheral blood (Zannas et al., 2019).”
BackgroundResultSelf-citationCausal links between mitophagy and Alzheimer’s disease: a Mendelian randomization studyPreprint
Zhang, W., Chen, W., Guo, Z., & Li, H. (2024) · medRxiv · doi:10.1101/2024.10.01.24314751 · Cited by 2
Linking Aβ and tau in the amyloid cascade through the intersection of their proteostasis networksPreprint
Lim, C. M., Hardy, J., & Vendruscolo, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646065 · Cited by 1
Single-cell, multi-region profiling of the macaque brain across the lifespan
Yang, W., Watkins, K., DeCasien, A. R., O’Neill, M. B., Bohlen, M. O., O’Day, D. R., Smith, E. A., Duran, M., 邱, 承., Meleshko, A., et al. (2026) · Cell · doi:10.1101/2025.10.31.685880 · Cited by 3
Age-associated increases in FKBP51 facilitate tau neurotoxicity
Blair, L. J. (2014) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Self-citationZannas, A. S., Klengel, T., Nemeroff, C. B., Carrillo‐Roa, T., Heim, C. C., Bradley, B., Ressler, K. J., & Binder, E. B. (2014) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(14)70234-2
“We have previously shown that CpGs in intron 7 GREs are sensitive to early trauma and glucocorticoid exposure [1] and are demethylated in the brain of older adults and Alzheimer’s disease patients [2].”
BackgroundSelf-citationEpigenetics of Glucocorticoid Action
Mifsud, K. R., Carter, S. D., Linthorst, A. C. E., & Reul, J. M. H. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00046-8 · Cited by 1
Inhibiting the Interaction Between Grp94 and Myocilin to Treat Primary Open-Angle Glaucoma
Stothert, A. R. (2016) · Digital Commons - University of South Florida (University of South Florida)
Approach for Alzheimer's Disease
Tian, H. (2014)
Successful aggregation of Tau protein labelled on its native cysteinesPreprint
Radli, M., Verdonschot, R. E., Ferrari, L., & Rüdiger, S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/211904
Molecular origins of tissue vulnerability to aberrant aggregation in protein misfolding diseases
Freer, R. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.22631
May, S. E. (2018) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-may-shannon-2018
The molecular mechanism of Hsp90-induced oligomerization of TauPreprint
Weickert, S., Wawrzyniuk, M., John, L., Rüdiger, S., & Drescher, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/614289
“The molecular chaperone Hsp90 (17, 18) initiates proteasomal degradation (19-21) and induces oligomerization of Tau (22-24).”
BackgroundResultRole of Hsp90 Interacting Molecular Chaperones on Tau and Aß Processing in Alzheimer’s Disease
Gracia, L., Lora, G., & Jinwal, U. K. (2019) · Heat shock proteins · doi:10.1007/978-3-030-24285-5_9
Exploring the human Hsp70-Hop-Hsp90 system for Tau recognition
Moll, A. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9131
Bayesian Random-Effects Meta-Analysis Models in Gene Expression Studies
Siangphoe, U. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103124 · Cited by 1
Faculty Opinions recommendation of SRCP1 conveys resistance to polyglutamine aggregation.
Gomer, R. H. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733671907.793549116
Anderson, R. T. (2022) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.11619
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegenerationPreprint
Hartmann, J., Bajaj, T., Otten, J., Klengel, C., Gellner, A., Junglas, E., Hafner, K., Anderzhanova, E. A., Tang, F., Missig, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.03.534570
Self-citationZhu, B., Cai, B., Xue, K., Yin, G., Zhou, S., & Fang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3296735/v1
Integrative Methods to Investigate Chaperones in Regulating Protein Phase Separation and Aggregation
Li, D., Zhang, S., & Liu, C. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781839165986-00319
Environmental factors and epigenetics of neuropsychiatric disorders
Peedicayil, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18516-8.00013-2
Sarkar, P., Moore, M., Özmen, A., Cetinkaya-Un, B., Vitko, J., Imudia, A. N., Lockwood, C. J., Kayisli, U. A., & Guzeloglu‐Kayisli, O. (2025) · F&S Science · doi:10.1016/j.xfss.2025.01.004 · Cited by 4
Edmond, K. Z., Kaul, D., Yusupov, N., Ködel, M., Sauer, S., Fröhlich, A. S., Tao, R. N., Kleinman, J. E., Weinberger, D. R., Hyde, T. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.28.635384
Self-citationMoore, M., Cetinkaya-Un, B., Sarkar, P., Kayisli, U. A., Semerci, N., Teng, M. N., Lockwood, C. J., & Guzeloglu‐Kayisli, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062471 · Cited by 1
“Additionally, we propose that PNS-mediated and/or age-related effects are mitigated in Fkbp5 − / − mice, potentially extending ovarian reproductive lifespan, as FKBP51 levels increase with age [35,51].”
Liu, H., Tang, M., Che, L., Lu, J., & Zhang, L. (2025) · NAM journal. · doi:10.1016/j.namjnl.2025.100044
“Tau, TDP-43, α -synuclein, and huntingtin protein can all act as client proteins of Hsp90, and an abnormally active HSP90 accelerates the formation of pathological aggregates of the above proteins [(Garcia-Toscano et al., 2024; Blair et al., 2013) -Baldo et al., 2012)].”
Molecular chaperones mediated proteostasis depletion: A cause of neurodegeneration?
Kinger, S., Choudhary, A., Kumar, P., Jagtap, Y. A., Sharma, V., Dhiman, R., Prasad, A., Verma, R., Chinnathambi, S., & Mishra, A. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.033
Metadata
- Authors
- Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., Cotman, C., Paulson, H. L., Muschol, M., Uversky, V. N., Klengel, T., Binder, E. B., Kayed, R., Golde, T. E., Berchtold, N., & Dickey, C. A.
- Affiliations
- University of South Florida (US)
- University of Michigan (US)
- University of California, Irvine (US)
- Max Planck Institute of Psychiatry (DE)
- The University of Texas Medical Branch at Galveston (US)
- University of Florida (US)
- Corresponding author
- Wang, Li
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-09-03
- Volume
- 123
- Issue
- 10
- Pages
- 4158-4169
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3784538
- OpenAlex
- W2056613924
- Cited by
- 322
- References
- 72
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 25 · 2023: 28 · 2022: 34 · 2021: 20 · 2020: 24 · 2019: 26 · 2018: 19 · 2017: 18 · 2016: 21 · 2015: 24 · 2014: 23 · 2013: 2
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- American Federation for Aging Research
- BrightFocus Foundation
- University of South Florida
- National Institutes of Health
- University of California, Irvine
- National Institute on Aging (P01AG000538, R01AG034667, P50AG016573)
- National Institute of Neurological Disorders and Stroke (K99NS073936, R00NS073936, R01NS073899, NS073899)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tau oligomerization, tau aggregation, tauopathy, Alzheimer's disease, FKBP51, HSP90, proteasome, tau clearance, amyloid fibril formation, neurotoxicity, tau transgenic mice
- MeSH terms
- Tacrolimus Binding Protein 5, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Animals, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Gene Expression, Case-Control Studies, tau Proteins, Mice, Knockout, HSP90 Heat-Shock Proteins, DNA Methylation, Protein Structure, Quaternary, Tacrolimus Binding Proteins, Proteasome Endopeptidase Complex, Mice, Protein Multimerization, Young Adult, CA3 Region, Hippocampal, HEK293 Cells, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.